Search

Search Constraints

You searched for: Author/Creator Qazi, Yasir

Search Results

5. Efficacy and Safety of Everolimus with Reduced-Dose Calcineurin Inhibitor in De Novo Kidney Transplant Recipients: Results from the TRANSFORM Study. (July 2018)

7. High levels of dd‐cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury. Issue 9 (10th March 2020)

9. Transplant administration—A survey of the roles and responsibilities of kidney and pancreas medical directors of US transplant centers. Issue 6 (27th April 2021)

10. Two‐year outcomes in de novo renal transplant recipients receiving everolimus‐facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study. Issue 11 (1st July 2019)